Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | PAM | P19021 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6646944 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CYP2D6ALOX15CYP1A2PAM | |
| SCHEMBL586254 | 0.80 | — | — | |
| SCHEMBL1130559 | 0.80 | — | — | |
| SCHEMBL12973054 | 0.80 | — | — | |
| SCHEMBL25929238 | 0.80 | ALDH1A1 (0.55) | ALDH1A1CYP2D6ALOX15CYP1A2PAM | |
| SCHEMBL10391009 | 0.79 | TSHR (0.44) | ALDH1A1CYP2D6ALOX15PAMMEN1 | |
| SCHEMBL8733629 | 0.78 | — | — | |
| SCHEMBL2917720 | 0.78 | — | — | |
| SCHEMBL8733627 | 0.78 | — | — | |
| SCHEMBL1759157 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117209375-A | Preparation method of polysubstituted chiral adipic acid compound containing quaternary carbon center | 四川大学 | 2023-12-12 | — | — | CN | disclosed |
| US-6828464-B2 | Preparation of cyclopentenones | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-07 | — | — | US | disclosed |
| US-20040102655-A1 | Preparation of cyclopentenoes | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-27 | — | — | US | disclosed |
| EP-1422212-A1 | Process for preparing cyclopentenone | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-26 | — | — | EP | disclosed |
| EP-0297447-B1 | METHOD FOR THE PREPARATION OF 2-CYCLOPENTENONES | BASF Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | disclosed |
| EP-0297447-A2 | Method for the preparation of 2-cyclopentenones | BASF Aktiengesellschaft (DE) | 1989-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102655-A1 | Preparation of cyclopentenoes | CYP17A1, CYP2F1, CYP2S1 | ALDH1A1 389/4885CYP2D6 60/4885ALOX15 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.